Foster City, CA, United States of America

Bei Li

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Kyorin Pharmaceutical Co., Ltd., Gilead Connecticut, Inc., Alfasigma S.p.a.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bei Li. Retrieved from https://idiyas.com/inventor/bei-li-va50al1z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

San Diego, CA (US) (2011 - 2014)
Foster City, CA (US) (2016 - 2024)

Company Filing History:

4 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

3 out of 30

Gilead Connecticut, Inc.

Years Active: 2011-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502394 - Pharmaceutical compositions comprising a JAK inhibitor (2025-12-23),

2. 11975008 - Pharmaceutical compositions comprising a JAK inhibitor (2024-05-07),

3. 9949932 - Formulation of syk inhibitors (2018-04-24),

4. 9918939 - Formulation of Syk inhibitors (2018-03-20),

5. 9382256 - Formulation of Syk inhibitors (2016-07-05),

6. 8901112 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2014-12-02),

7. 8476261 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2013-07-02),

8. 8389514 - Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors (2013-03-05),

9. 8063221 - Aminoquinolones as GSK-3 inhibitors (2011-11-22),

Title: The Innovative Journey of Inventor Bei Li

Introduction

Bei Li, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals, particularly through his innovative research. With a total of four patents to his name, Bei Li's work is centered around developing solutions for complex medical challenges.

Latest Patents

Among his latest patents, Bei Li has introduced spirocyclic aminoquinolones as GSK-3 inhibitors. These compounds are notable for their potential to provide therapeutic benefits in the prevention, amelioration, or treatment of diseases mediated by GSK-3 inhibitors. The formula includes specific structures where X can be either O or NR, and A is defined as bond or substituted/unsubstituted C-Calkylene. This innovative composition demonstrates the utility of spirocyclic aminoquinolones in addressing critical health issues.

Career Highlights

Currently, Bei Li is associated with Kyorin Pharmaceutical Co., Ltd., a company known for its commitment to advancing medical technology and drug development. His dedication to research and innovation within this company's framework has positioned him as a key figure in his field.

Collaborations

Throughout his career, Bei Li has collaborated with esteemed colleagues such as Anna Katrin Szardenings and Oana Cociorva. These partnerships have fostered a productive environment for innovation, enabling the team to explore and develop cutting-edge pharmaceutical solutions.

Conclusion

In summary, Bei Li's contributions to the innovation landscape illustrate the profound impact of dedicated research and collaboration in addressing complex medical challenges. As he continues his work with Kyorin Pharmaceutical Co., Ltd., the potential for his inventions to revolutionize treatment options remains promising.

Profile summary based on public USPTO records.